Plante Moran Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $624 | Buy |
+1
| New | +$681 | ﹤0.01% | 1055 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$2.63K | – | 920 |
|
|
2023
Q4 | $2.63K | Buy |
+3
| New | +$2.47K | ﹤0.01% | 702 |
|
|
2022
Q4 | – | Sell |
-5
| Closed | -$3K | – | 952 |
|
|
2022
Q3 | $3K | Hold |
5
| – | – | ﹤0.01% | 761 |
|
|
2022
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 780 |
|
|
2022
Q1 | $3K | Sell |
5
-5
| -50% | -$3.16K | ﹤0.01% | 723 |
|
|
2021
Q4 | $6K | Sell |
10
-119
| -92% | -$73.2K | ﹤0.01% | 794 |
|
|
2021
Q3 | $78K | Buy |
129
+6
| +5% | +$3.73K | 0.02% | 304 |
|
|
2021
Q2 | $69K | Buy |
123
+18
| +17% | +$9.12K | 0.02% | 309 |
|
|
2021
Q1 | $50K | Sell |
105
-2
| -2% | -$974 | 0.01% | 368 |
|
|
2020
Q4 | $52K | Buy |
+107
| New | +$57.8K | 0.02% | 354 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$98K | – | 827 |
|
|
2020
Q1 | $98K | Buy |
+200
| New | +$82.5K | 0.04% | 194 |
|
|
2019
Q4 | – | Sell |
-73
| Closed | -$20K | – | 873 |
|
|
2019
Q3 | $20K | Sell |
73
-120
| -62% | -$35.5K | 0.01% | 501 |
|
|
2019
Q2 | $60K | Sell |
193
-6
| -3% | -$2K | 0.02% | 305 |
|
|
2019
Q1 | $82K | Buy |
199
+110
| +124% | +$45.3K | 0.03% | 246 |
|
|
2018
Q4 | $33K | Buy |
89
+3
| +3% | +$1.1K | 0.01% | 366 |
|
|
2018
Q3 | $35K | Sell |
86
-3
| -3% | -$1.14K | 0.01% | 361 |
|
|
2018
Q2 | $31K | Sell |
89
-6
| -6% | -$1.88K | 0.02% | 416 |
|
|
2018
Q1 | $33K | Buy |
95
+16
| +20% | +$5.57K | 0.02% | 423 |
|
|
2017
Q4 | $30K | Hold |
79
| – | – | 0.02% | 436 |
|
|
2017
Q3 | $35K | Buy |
79
+6
| +8% | +$2.85K | 0.02% | 378 |
|
|
2017
Q2 | $36K | Hold |
73
| – | – | 0.02% | 376 |
|
|
2017
Q1 | $28K | Hold |
73
| – | – | 0.02% | 419 |
|
|
2016
Q4 | $27K | Hold |
73
| – | – | 0.02% | 434 |
|
|
2016
Q3 | $29K | Sell |
73
-5
| -6% | -$2.01K | 0.02% | 412 |
|
|
2016
Q2 | $27K | Buy |
78
+5
| +7% | +$1.93K | 0.02% | 383 |
|
|
2016
Q1 | $26K | Hold |
73
| – | – | 0.02% | 348 |
|
|
2015
Q4 | $40K | Hold |
73
| – | – | 0.03% | 318 |
|
|
2015
Q3 | $34K | Hold |
73
| – | – | 0.03% | 318 |
|
|
2015
Q2 | $37K | Hold |
73
| – | – | 0.03% | 337 |
|
|
2015
Q1 | $33K | Sell |
73
-7
| -9% | -$2.97K | 0.02% | 338 |
|
|
2014
Q4 | $33K | Buy |
80
+7
| +10% | +$2.75K | 0.02% | 336 |
|
|
2014
Q3 | $26K | Buy |
+73
| New | +$24.5K | 0.02% | 362 |
|
Other funds holding REGN
Plante Moran Financial Advisors's REGN Position: Q2 2026 in Review
Plante Moran Financial Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1 share worth $624. The stake represents ﹤0.01% of the portfolio and ranks #1055 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in REGN as recently as Q4 2023.
Plante Moran Financial Advisors first reported a position in REGN in Q3 2014 and has held it in 32 quarters since. The position peaked at $98K in Q1 2020. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Plante Moran Financial Advisors held 1 share of Regeneron Pharmaceuticals worth $624 as of Q2 2026.
- Regeneron Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1055 holding.
- Plante Moran Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 32 quarters since.
- Plante Moran Financial Advisors's Regeneron Pharmaceuticals position peaked at $98K in Q1 2020.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.